Related Experiment Video
Updated: Mar 15, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Pulmonary Hypertension and Atrial Septal Defect: Management Dilemma
Karim El-Kersh1, Molly Howsare, Ali Zaidi
11Department of Medicine, Division of Pulmonary, Critical Care and Sleep Disorders Medicine, University of Louisville, Louisville, KY; 2Department of Medicine, Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; and 3Department of Medicine, Division of Cardiology, University of Louisville, Louisville, KY.
Abstract:
The decision making in patients with an atrial septal defect (ASD) in setting of pulmonary hypertension is complex. In the era of pulmonary arterial vasodilator therapy, every patient should undergo evaluation by pulmonary hypertension experts especially if defect closure is being considered. Defect closure in the inappropriate group can lead to poor outcomes.
Related Concept Videos
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Rheumatic Heart Disease III: Medical Management

